tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CRVS Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
7d ago
CRVS
PHAT
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
7d ago
FTI
SAP
Corvus Pharmaceuticals Reports Strong Q1 2025 Earnings
PremiumCompany Announcements
Corvus Pharmaceuticals Reports Strong Q1 2025 Earnings
10d ago
CRVS
Corvus Pharmaceuticals price target raised to $17 from $15 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $17 from $15 at Oppenheimer
10d ago
CRVS
Corvus Pharmaceuticals: Promising AD Treatment Developments and Strategic Expansion Justify Buy Rating
PremiumRatings
Corvus Pharmaceuticals: Promising AD Treatment Developments and Strategic Expansion Justify Buy Rating
10d ago
CRVS
Corvus Pharmaceuticals Reports Promising Q1 2025 Results
PremiumCompany AnnouncementsCorvus Pharmaceuticals Reports Promising Q1 2025 Results
10d ago
CRVS
Corvus Pharmaceuticals Reports Positive Phase 1 Trial Results
Premium
Company Announcements
Corvus Pharmaceuticals Reports Positive Phase 1 Trial Results
11d ago
8K
CRVS
Corvus Pharmaceuticals reports Q1 EPS (13c), consensus (12c)
Premium
The Fly
Corvus Pharmaceuticals reports Q1 EPS (13c), consensus (12c)
11d ago
CRVS
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
CRVS
Corvus Pharmaceuticals Appoints New Director to Board
PremiumCompany Announcements
Corvus Pharmaceuticals Appoints New Director to Board
1M ago
8K
CRVS
Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
2M ago
CRVS
Corvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
2M ago
CRVS
Corvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsCorvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
2M ago
CRVS
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
Premium
The Fly
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
2M ago
CRVS
Options Volatility and Implied Earnings Moves Today, March 25, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 25, 2025
2M ago
GME
MKC
Corvus announces presentation of data from Phase 1/1b trial of soquelitinib
PremiumThe Fly
Corvus announces presentation of data from Phase 1/1b trial of soquelitinib
2M ago
CRVS
Corvus Pharmaceuticals announces initiation of Phase 2 trial of soquelitinib
PremiumThe Fly
Corvus Pharmaceuticals announces initiation of Phase 2 trial of soquelitinib
2M ago
CRVS
CRVS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CRVS Upcoming Earnings Report: What to Expect?
3M ago
CRVS
Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib
PremiumCompany Announcements
Corvus Pharmaceuticals Reports Promising Interim Data on Soquelitinib
4M ago
8K
CRVS
Corvus announces data from cohort 2 of Phase 1 trial of Soquelitinib
PremiumThe FlyCorvus announces data from cohort 2 of Phase 1 trial of Soquelitinib
4M ago
CRVS
Alphabet, Uber downgraded: Wall Street’s top analyst calls
Premium
The Fly
Alphabet, Uber downgraded: Wall Street’s top analyst calls
5M ago
AYI
LHX
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
5M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >